- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
下跌有所减缓，仍应保持谨慎。
- 长期趋势：
已有204家主力机构披露2026-06-30报告期持股数据，持仓量总计4.52亿股，占流通A股79.02%
- 波段诊断：
-
技术面诊股
诊断结果：6.0技术面打败了75%的股票
技术面评分前10的股票
近期的平均成本为33.98元。空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
平均成本
近期的平均成本为33.98元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"33.98","date":1790153493,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，接近行业平均水平。
[{"date":"2026.09.24","stock":"-2.29","trade":null,"ind":"-1.22"},{"date":"2026.09.23","stock":"-1.52","trade":null,"ind":"-0.39"},{"date":"2026.09.22","stock":"7.53","trade":null,"ind":"0.06"},{"date":"2026.09.21","stock":"1.09","trade":null,"ind":"0.97"},{"date":"2026.09.18","stock":"0.03","trade":null,"ind":"0.94"},{"date":"2026.09.17","stock":"0.78","trade":null,"ind":"-0.41"},{"date":"2026.09.16","stock":"0.57","trade":null,"ind":"0.71"},{"date":"2026.09.15","stock":"0.00","trade":null,"ind":"-0.54"},{"date":"2026.09.14","stock":"1.89","trade":null,"ind":"-0.07"},{"date":"2026.09.11","stock":"-3.08","trade":null,"ind":"-1.18"},{"date":"2026.09.10","stock":"0.22","trade":null,"ind":"-0.43"},{"date":"2026.09.09","stock":"-0.53","trade":null,"ind":"0.28"},{"date":"2026.09.08","stock":"-0.86","trade":null,"ind":"0.20"},{"date":"2026.09.07","stock":"-1.43","trade":null,"ind":"0.07"},{"date":"2026.09.04","stock":"1.82","trade":null,"ind":"-0.30"},{"date":"2026.09.03","stock":"-1.70","trade":null,"ind":"0.02"},{"date":"2026.09.02","stock":"-0.42","trade":null,"ind":"-0.97"},{"date":"2026.09.01","stock":"0.52","trade":null,"ind":"-0.16"},{"date":"2026.08.31","stock":"-0.45","trade":null,"ind":"0.86"},{"date":"2026.08.28","stock":"-1.34","trade":null,"ind":"-0.11"},{"date":"2026.08.27","stock":"0.33","trade":null,"ind":"1.13"}]
安图生物,上证指数,医疗器械指数
压力支撑
该股压力位为34.07元，支撑位为33.37元。
[{"text":"\u538b\u529b\u4f4d","value":"34.07","date":1790179200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"33.37","date":1790179200,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前反弹趋势有所减缓，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：8.9资金面打败了99%的股票
主力控盘前10的股票
行业资金
医疗器械行业， 近5日资金总体呈流入状态，投资者可考虑关注该行业的个股。
更新时间：09月25日 20:32
| 机构今日流向(万元) | -1006.05 | 机构5日流向(万元) | 1261.19 |
| 机构10日流向(万元) | 459.79 | 机构20日流向(万元) | -2969.83 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量增加162.70万股，其中基金净增仓6家，主力净增仓15家，有一定的中长期投资价值。
截止2026-06-30，共204家主力机构（基金201家，一般法人3家），持仓量总计45154.75万股，占流通A股79.02%
其中，基金持仓与2025-12-31相比：
增仓：63家 ，增持 276.25万股
减仓：57家 ，减持 497.41万股
新出现在主力名单中：64家 ，持有857.69万股
从主力名单中消失：49家 ，原持有352.56万股
其中，基金持仓与2025-12-31相比：
增仓：63家 ，增持 276.25万股
减仓：57家 ，减持 497.41万股
新出现在主力名单中：64家 ，持有857.69万股
从主力名单中消失：49家 ，原持有352.56万股
消息面诊股
诊断结果：5.5消息面打败了67%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 大利好！《医药工业发展“十五五”规划》点名，赛道核
2026-09-24 - 安图生物：9月23日获融资买入2170.24万元
2026-09-24 - 37国、200余位专家！2026国际微生物检验医学
2026-09-23 - 安图生物：9月22日获融资买入6750.53万元
2026-09-23 - 【中原晨会0923】市场分析、安图生物中报点评专题
2026-09-23 - 【中原医药】安图生物2026年中报点评：主营产品稳
2026-09-23 - 中庚价值先锋股票重仓股安图生物涨7.53%
2026-09-22 - 安图生物：9月21日获融资买入731.57万元
2026-09-22 - 安图生物：公司将于9月30日召开2026年半年度业
2026-09-21 - 2026年，医药产业互补合作正持续落地！
2026-09-21
消息列表
| 一般消息 | 募资投向 | 2026-09-17 | |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-08-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-25 |
| 一般消息 | 高管变动 | 工作调整 | 2026-04-23 |
| 利好 | 分红转增 | 10派13.10元(含税) | 2026-04-23 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-14 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：0.0行业面打败了9%的股票
医疗器械行业最新资金流向
-
行业走势
[{"date":"2026.09.24","price":"-1.22","value":null},{"date":"2026.09.23","price":"-0.39","value":null},{"date":"2026.09.22","price":"0.06","value":null},{"date":"2026.09.21","price":"0.97","value":null},{"date":"2026.09.18","price":"0.94","value":null},{"date":"2026.09.17","price":"-0.41","value":null},{"date":"2026.09.16","price":"0.71","value":null},{"date":"2026.09.15","price":"-0.54","value":null},{"date":"2026.09.14","price":"-0.07","value":null},{"date":"2026.09.11","price":"-1.18","value":null},{"date":"2026.09.10","price":"-0.43","value":null},{"date":"2026.09.09","price":"0.28","value":null},{"date":"2026.09.08","price":"0.20","value":null},{"date":"2026.09.07","price":"0.07","value":null},{"date":"2026.09.04","price":"-0.30","value":null},{"date":"2026.09.03","price":"0.02","value":null},{"date":"2026.09.02","price":"-0.97","value":null},{"date":"2026.09.01","price":"-0.16","value":null},{"date":"2026.08.31","price":"0.86","value":null},{"date":"2026.08.28","price":"-0.11","value":null},{"date":"2026.08.27","price":"1.13","value":"-357279036.44"}]
上证指数,医疗器械行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 洁特生物 | 65.81% | 23.51% | 5.2分 |
| 2 | 采纳股份 | 64.10% | 34.88% | 5.8分 |
| 3 | 浩欧博 | 40.59% | 18.86% | 5.3分 |
| 4 | 奥精医疗 | 34.59% | 25.46% | 5.5分 |
| 5 | 透景生命 | 19.36% | 23.37% | 5.3分 |
| 6 | 博拓生物 | 16.98% | 14.88% | 5.3分 |
| 8 | 艾德生物 | 14.91% | 20.22% | 6.1分 |
| 10 | 海尔生物 | 11.61% | 12.92% | 6.0分 |
| 12 | 安杰思 | 10.29% | 4.88% | 5.2分 |
| 14 | 南微医学 | 9.41% | 1.30% | 6.2分 |
| 16 | 之江生物 | 8.32% | 15.31% | 4.9分 |
| 18 | 华大智造 | 7.83% | 13.12% | 5.8分 |
| 20 | 东富龙 | 6.77% | 10.93% | 5.7分 |
| 22 | 拱东医疗 | 6.35% | 5.40% | 6.1分 |
| 24 | 基蛋生物 | 6.05% | 5.25% | 5.9分 |
| 26 | 英诺特 | 5.18% | 5.74% | 4.8分 |
| 28 | 戴维医疗 | 4.56% | 11.64% | 5.7分 |
| 30 | 楚天科技 | 4.47% | 17.09% | 5.4分 |
| 32 | 澳华内镜 | 4.26% | 5.45% | 5.1分 |
| 34 | 康为世纪 | 4.03% | 3.34% | 5.1分 |
| 36 | 天益医疗 | 3.21% | 1.74% | 5.8分 |
| 38 | 宝莱特 | 3.15% | 4.66% | 4.9分 |
| 40 | 东星医疗 | 3.04% | 8.94% | 5.1分 |
| 42 | 瑞迈特 | 2.89% | 5.42% | 5.4分 |
| 44 | 仁度生物 | 2.50% | 8.85% | 5.5分 |
| 46 | 祥生医疗 | 2.08% | 6.50% | 5.4分 |
| 48 | - | 1.82% | 3.62% | 分 |
| 50 | 凯普生物 | 1.63% | 7.24% | 5.2分 |
| 52 | 爱迪特 | 1.54% | 4.21% | 5.8分 |
| 54 | 天臣医疗 | 1.29% | 13.86% | 5.7分 |
| 56 | 安旭生物 | 1.15% | 5.22% | 5.1分 |
| 58 | 达安基因 | 0.89% | 7.59% | 5.5分 |
| 60 | - | 0.84% | 0.84% | 分 |
| 62 | 济民健康 | 0.36% | 6.03% | 4.9分 |
| 64 | 三诺生物 | 0.12% | 3.59% | 6.2分 |
| 66 | 万孚生物 | -0.12% | 4.06% | 4.6分 |
| 68 | 昊海生科 | -0.20% | 4.33% | 5.3分 |
| 70 | 三友医疗 | -0.30% | 7.26% | 5.4分 |
| 72 | *ST海利 | -0.32% | 0.99% | 3.6分 |
| 74 | 尚荣医疗 | -0.59% | 1.82% | 5.1分 |
| 76 | 济高发展 | -1.12% | 0.76% | 4.2分 |
| 78 | 康泰医学 | -1.21% | 8.32% | 5.0分 |
| 80 | 开立医疗 | -1.53% | 3.83% | 5.1分 |
| 82 | 天智航 | -1.61% | 4.30% | 4.4分 |
| 84 | 理邦仪器 | -1.94% | 2.84% | 5.7分 |
| 86 | 东方生物 | -2.09% | 6.44% | 4.9分 |
| 88 | - | -2.11% | 0.36% | 分 |
| 90 | 麦克奥迪 | -2.41% | 4.52% | 4.6分 |
| 92 | - | -2.56% | 3.31% | 分 |
| 94 | 超研股份 | -2.71% | 5.61% | 5.6分 |
| 96 | 维力医疗 | -2.81% | 2.88% | 5.5分 |
| 98 | 山东药玻 | -3.14% | 1.05% | 5.4分 |
| 100 | 利德曼 | -3.57% | 3.66% | 4.4分 |
| 102 | 易瑞生物 | -4.10% | 3.97% | 5.0分 |
| 104 | 中源协和 | -4.20% | 4.76% | 5.6分 |
| 106 | - | -4.33% | 0.51% | 分 |
| 108 | 亚辉龙 | -4.46% | 6.64% | 6.0分 |
| 110 | - | -5.39% | 1.99% | 分 |
| 112 | 健帆生物 | -5.91% | -0.47% | 5.0分 |
| 114 | 新产业 | -6.01% | -2.75% | 5.7分 |
| 116 | 三鑫医疗 | -6.14% | 1.58% | 5.7分 |
| 118 | 健信超导 | -6.36% | 2.15% | 5.3分 |
| 120 | 心脉医疗 | -6.42% | 1.02% | 5.3分 |
| 122 | 力诺药包 | -6.78% | 6.46% | 5.4分 |
| 124 | 热景生物 | -7.08% | 4.69% | 4.9分 |
| 126 | 欧普康视 | -8.69% | 1.10% | 4.4分 |
| 128 | 国发股份 | -8.83% | -3.46% | 4.0分 |
| 130 | 大博医疗 | -8.88% | 6.85% | 6.3分 |
| 132 | 海泰新光 | -9.18% | 1.26% | 4.4分 |
| 134 | 华兰股份 | -9.57% | 14.08% | 5.8分 |
| 136 | 九安医疗 | -11.14% | 2.10% | 5.8分 |
| 138 | 英科医疗 | -12.23% | -4.40% | 4.7分 |
| 140 | 微电生理 | -16.39% | 3.86% | 5.6分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 24/246 ， 28/246。
[{"date":"2026-06-30","value":"5.65","vol":"2.35"},{"date":"2026-03-31","value":"2.61","vol":"1.12"},{"date":"2025-12-31","value":"12.18","vol":"2.37"},{"date":"2025-09-30","value":"9.90","vol":"3.06"},{"date":"2025-06-30","value":"6.69","vol":"2.40"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
5.65 | 2.61 | 12.18 | 9.90 | 6.69 |
| 行业(%) | 2.35 | 1.12 | 2.37 | 3.06 | 2.40 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"67.25","vol":"52.38"},{"date":"2026-03-31","value":"66.64","vol":"52.12"},{"date":"2025-12-31","value":"65.64","vol":"51.82"},{"date":"2025-09-30","value":"64.83","vol":"52.03"},{"date":"2025-06-30","value":"64.43","vol":"52.36"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
67.25 | 66.64 | 65.64 | 64.83 | 64.43 |
| 行业(%) | 52.38 | 52.12 | 51.82 | 52.03 | 52.36 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 81/246 ， 78/246。
[{"date":"2026-06-30","value":"-0.12","vol":"5.46"},{"date":"2026-03-31","value":"-0.37","vol":"5.59"},{"date":"2025-12-31","value":"-5.47","vol":"1.01"},{"date":"2025-09-30","value":"-7.48","vol":"0.11"},{"date":"2025-06-30","value":"-6.65","vol":"-1.37"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-0.12 | -0.37 | -5.47 | -7.48 | -6.65 |
| 行业(%) | 5.46 | 5.59 | 1.01 | 0.11 | -1.37 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-12.94","vol":"-24.55"},{"date":"2026-03-31","value":"-12.39","vol":"-20.93"},{"date":"2025-12-31","value":"-10.59","vol":"-33.44"},{"date":"2025-09-30","value":"-10.11","vol":"-15.21"},{"date":"2025-06-30","value":"-7.83","vol":"-17.88"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-12.94 | -12.39 | -10.59 | -10.11 | -7.83 |
| 行业(%) | -24.55 | -20.93 | -33.44 | -15.21 | -17.88 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 60/246 ， 89/246。
[{"date":"2026-06-30","value":"0.17","vol":"0.17"},{"date":"2026-03-31","value":"0.08","vol":"0.08"},{"date":"2025-12-31","value":"0.35","vol":"0.35"},{"date":"2025-09-30","value":"0.27","vol":"0.25"},{"date":"2025-06-30","value":"0.18","vol":"0.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.08 | 0.35 | 0.27 | 0.18 |
| 行业(次) | 0.17 | 0.08 | 0.35 | 0.25 | 0.17 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.69","vol":"1.12"},{"date":"2026-03-31","value":"0.35","vol":"0.55"},{"date":"2025-12-31","value":"1.39","vol":"2.33"},{"date":"2025-09-30","value":"1.01","vol":"1.66"},{"date":"2025-06-30","value":"0.65","vol":"1.12"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.69 | 0.35 | 1.39 | 1.01 | 0.65 |
| 行业(次) | 1.12 | 0.55 | 2.33 | 1.66 | 1.12 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 96/246 ， 61/246。
[{"date":"2026-06-30","value":"6.50","vol":"14.81"},{"date":"2026-03-31","value":"14.77","vol":"-0.33"},{"date":"2025-12-31","value":"45.15","vol":"32.14"},{"date":"2025-09-30","value":"40.80","vol":"14.86"},{"date":"2025-06-30","value":"22.91","vol":"15.69"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 6.50 | 14.77 | 45.15 | 40.80 | 22.91 |
| 行业 | 14.81 | -0.33 | 32.14 | 14.86 | 15.69 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.95","vol":"1.31"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"1.23","vol":"1.62"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"1.32","vol":"1.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.95 | - | 1.23 | - | 1.32 |
| 行业 | 1.31 | 0.00 | 1.62 | 0.01 | 1.58 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 21/246 ， 7/246。
[{"date":"2026-06-30","value":"2.42","vol":"5.78"},{"date":"2026-03-31","value":"2.67","vol":"6.17"},{"date":"2025-12-31","value":"2.40","vol":"5.27"},{"date":"2025-09-30","value":"2.58","vol":"5.64"},{"date":"2025-06-30","value":"2.34","vol":"5.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
2.42 | 2.67 | 2.40 | 2.58 | 2.34 |
| 行业 | 5.78 | 6.17 | 5.27 | 5.64 | 5.45 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"1.08","vol":"4.71"},{"date":"2026-03-31","value":"0.95","vol":"5.04"},{"date":"2025-12-31","value":"0.88","vol":"4.13"},{"date":"2025-09-30","value":"0.92","vol":"4.49"},{"date":"2025-06-30","value":"0.85","vol":"4.34"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
1.08 | 0.95 | 0.88 | 0.92 | 0.85 |
| 行业 | 4.71 | 5.04 | 4.13 | 4.49 | 4.34 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 49/246 ， 50/246。
[{"date":"2026-06-30","value":"25.60","vol":"23.17"},{"date":"2026-03-31","value":"24.40","vol":"22.26"},{"date":"2025-12-31","value":"26.64","vol":"23.19"},{"date":"2025-09-30","value":"24.57","vol":"22.23"},{"date":"2025-06-30","value":"26.57","vol":"22.18"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
25.60 | 24.40 | 26.64 | 24.57 | 26.57 |
| 行业(%) | 23.17 | 22.26 | 23.19 | 22.23 | 22.18 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.35","vol":"0.42"},{"date":"2026-03-31","value":"0.33","vol":"0.40"},{"date":"2025-12-31","value":"0.37","vol":"0.41"},{"date":"2025-09-30","value":"0.33","vol":"0.72"},{"date":"2025-06-30","value":"0.37","vol":"0.58"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.35 | 0.33 | 0.37 | 0.33 | 0.37 |
| 行业(%) | 0.42 | 0.40 | 0.41 | 0.72 | 0.58 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中原证券 | 2026-09-22 | 增持 | |
| 华创证券 | 2026-09-17 | 增持 | |
| 申万宏源 | 2026-09-08 | 买入 | |
| 华泰证券 | 2026-09-04 | 买入 | 买入 |
| 国联民生 | 2026-08-29 | 买入 | |
| 中国银河 | 2026-08-28 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"11.67","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"12.17","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"11.94","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"10.68","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"11.16","blueLineValue":"1.95","type":"YC"}]